GlassScriptPhysician profile
Siddharth Chinta
NPI 1184250565
$5,055.35
in general payments reported to CMS, 2019-2025
21 companies · $3,717 in 2025
The $3,717 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.60 · 2023: $18.89 · 2024: $1,298 · 2025: $3,717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,871 · Travel and Lodging: $675 · Education: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,871.29 |
| Travel and Lodging | $675.20 |
| Education | $487.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,501.84 | 2024-2025 | Gallant, Ensite, Aveir |
| Abiomed | $1,221.06 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $328.78 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $245.12 | 2024-2025 | Camzyos |
| Amgen INC. | $231.12 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $185.45 | 2025 | |
| Recor Medical INC | $184.32 | 2025 | Paradise Ultrasound Renal Denervation System |
| Terumo Medical Corporation | $169.49 | 2024-2025 | Optitorque, Metacross Otw, Glidewire |
| Novo Nordisk INC | $135.92 | 2024 | Wegovy |
| Shockwave Medical, INC | $135.01 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $115.52 | 2025 | Wainua |
| Vital Connect, INC | $111.58 | 2024-2025 | Vitalpatch Rtm |
| Alnylam Pharmaceuticals INC. | $98.93 | 2025 | Amvuttra |
| Pfizer INC. | $94.87 | 2024 | |
| Medtronic, INC. | $87.64 | 2025 | Aurora Ev-Icd Mri Surescan, Micra |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $59.60 | 2024 | Alphavac |
| Kiniksa Pharmaceuticals International, Plc | $53.13 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $37.28 | 2024 | |
| Philips North America LLC | $21.60 | 2022 | |
| Biotronik INC. | $18.64 | 2024 | |
| Janssen Pharmaceuticals, INC | $18.45 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Siddharth Chinta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.